Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 3Mesothelioma 3Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Thymoma 1Ovarian Neoplasms 1Mesothelioma, Malignant 1Medical Oncology 1Fallopian Tube Endometrioid Adenocarcinoma 1Cholangiocarcinoma 1Adenocarcinoma of Lung 1

Interventions

Itraconazole 2roniciclib 1aprutumab ixadotin 1anetumab ravtansine 1Diet 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Medical Oncology × anetumab ravtansine × Clear all
NCT02824042 2020-07-31

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Bayer

Phase 1 Completed
63 enrolled

Medical Oncology

Data powered by HemOnc (CC BY 4.0) Colophon âš¡